ClinicalTrials.govpublic full text
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
breast cancer, intermittent fasting, obesity, overweight, hormone receptor positive, her2-negative, human epidermal growth factor receptor 2-negative, hr-positive, hr+/her2-, early breast cancer, adjuvant endocrine therapy, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 918714
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.